Maximus vs BMI MD: Compare GLP-1 Programs & Pricing
Side-by-side Maximus and BMI MD: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
Maximus and BMI MD are telehealth providers offering GLP-1–based weight management programs through virtual evaluations and pharmacy fulfillment. This comparison highlights pricing, medical workflow, medication quality, and patient support so you can choose the option that fits your needs.
Maximus vs BMI MD: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| Maximus | $132.99 | — | — No | |
| BMI MD | — | — |
How to read this table: empty fields indicate the provider does not list a starting price publicly on their landing page or pricing sheet at the time of this writing. Prices can vary by dose, supply length, and pharmacy used.
Maximus vs BMI MD: Medical Process & Accessibility
Both providers use a telehealth model where you complete an intake questionnaire and a licensed clinician reviews your medical history before any prescription is issued. Maximus emphasizes a streamlined intake designed for faster approvals; BMI MD promotes structured follow-up visits and dose adjustments as part of an ongoing care plan. Neither platform replaces in-person emergency care, and both require a clinician evaluation to determine suitability.
Maximus vs BMI MD: Pricing Comparison
Transparent pricing matters when choosing a GLP-1 telehealth program. Maximus publicly lists tirzepatide at $132.99 for the referenced formulation, while semaglutide pricing is not posted on their public page. BMI MD does not list a starting price for semaglutide or tirzepatide on the pages referenced here. When one provider shows a price and the other does not, the listed number is the only available public reference and is highlighted for clarity.
Because prices depend on dose, supply length (e.g., 30-day vs 90-day), pharmacy selection, and any promotional offers, we recommend confirming the exact cost during the intake process. Neither provider’s price guarantees include insurance coverage; many commercial insurers do not cover compounded formulations for weight loss.
Compare Maximus Pricing
Compare BMI MD Pricing
Maximus vs BMI MD: Clinical Oversight & Support
Both services connect you with licensed clinicians in the U.S. who evaluate safety, contraindications, and medication interactions. Typical care includes an initial virtual assessment, prescription initiation when appropriate, and recommended follow-ups. BMI MD emphasizes more frequent follow-up touchpoints in patient reports, while Maximus highlights a quicker onboarding process.
Maximus vs BMI MD: Medication Quality & Safety
Both programs commonly route prescriptions through accredited U.S. pharmacies, which may provide compounded GLP-1 formulations. Important regulatory note: compounded versions are not FDA-approved equivalents of branded products like Wegovy® or Mounjaro®. Licensed clinicians must determine clinical appropriateness; FDA-approved alternatives and branded medications may have different dosing, safety profiles, and evidence. All patients should disclose full medical history and current medications and follow clinician instructions closely.
Maximus vs BMI MD: Customer Experience
Patient reports typically praise Maximus for affordability and speed, while BMI MD receives positive notes for attentive clinical communication and structured follow-ups. Shipping times and availability vary by pharmacy and location; ask each provider about return policies, refill scheduling, and how adverse reactions are handled.
Maximus vs BMI MD: Final Verdict
If your priority is a lower published per-dose price and rapid onboarding, Maximus may be preferable. If you prefer a program that emphasizes ongoing clinician contact and dose optimization, BMI MD may better match your needs. In all cases, choose a licensed telehealth provider, confirm pharmacy sourcing, and follow up with your clinician regarding side effects and treatment goals.
Join Maximus
Get Started with BMI MD
Disclaimer
This article is for informational purposes only and does not constitute medical advice. GLP1Talks & GLP1Discussions may receive affiliate commissions at no cost to you. Always consult a licensed clinician before beginning or changing any medical treatment; only a qualified provider can assess risks, contraindications, and the appropriateness of GLP-1 therapy for your situation.